1,2-dimethylhydrazine increases expression ISO RGD:11205 6480464 1, 2-Dimethylhydrazine results in increased expression of H2-M3 mRNA CTD PMID:22206623 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of RT1-M3-1 mRNA CTD PMID:25380136 17beta-estradiol increases expression ISO RGD:1347423 6480464 Estradiol results in increased expression of HLA-G mRNA CTD PMID:19619570 , PMID:21185374 17beta-estradiol multiple interactions ISO RGD:1347423 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of HLA-G mRNA CTD PMID:19619570 2,2',4,4'-Tetrabromodiphenyl ether increases expression EXP 6480464 2 more ... CTD PMID:27291303 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1347423 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of HLA-G mRNA CTD PMID:19619570 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:11205 6480464 Tetrachlorodibenzodioxin affects the expression of H2-M3 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of RT1-M3-1 mRNA CTD PMID:33387578 , PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1347423 6480464 Tetrachlorodibenzodioxin affects the expression of HLA-G mRNA CTD PMID:22574217 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1347423 6480464 Tetrachlorodibenzodioxin results in increased expression of HLA-G mRNA CTD PMID:19619570 2,6-dinitrotoluene affects expression EXP 6480464 2, 6-dinitrotoluene affects the expression of RT1-M3-1 mRNA CTD PMID:21346803 4,4'-diaminodiphenylmethane increases expression EXP 6480464 4, 4'-diaminodiphenylmethane results in increased expression of RT1-M3-1 mRNA CTD PMID:25380136 4,4'-sulfonyldiphenol decreases expression ISO RGD:11205 6480464 bis(4-hydroxyphenyl)sulfone results in decreased expression of H2-M3 mRNA CTD PMID:33297965 5-aza-2'-deoxycytidine multiple interactions ISO RGD:1347423 6480464 [Decitabine affects the methylation of HLA-G promoter] which affects the expression of HLA-G mRNA, [Decitabine affects the methylation of HLA-G promoter] which affects the expression of HLA-G protein CTD PMID:18498645 , PMID:18823661 5-aza-2'-deoxycytidine increases expression ISO RGD:1347423 6480464 Decitabine results in increased expression of HLA-G mRNA, Decitabine results in increased expression of HLA-G protein CTD PMID:17949227 5-fluorouracil increases expression ISO RGD:1347423 6480464 Fluorouracil results in increased expression of HLA-G mRNA CTD PMID:16101138 5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole affects expression ISO RGD:1347423 6480464 Omeprazole affects the expression of HLA-G mRNA CTD PMID:25811541 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of RT1-M3-1 mRNA CTD PMID:24780913 acetamide increases expression EXP 6480464 acetamide results in increased expression of RT1-M3-1 mRNA CTD PMID:31881176 acetylsalicylic acid decreases expression ISO RGD:1347423 6480464 Aspirin results in decreased expression of HLA-G mRNA CTD PMID:14976132 all-trans-retinoic acid increases expression ISO RGD:1347423 6480464 Tretinoin results in increased expression of HLA-G mRNA CTD PMID:15498508 more ... ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of RT1-M3-1 mRNA CTD PMID:16483693 antirheumatic drug decreases expression ISO RGD:1347423 6480464 Antirheumatic Agents results in decreased expression of HLA-G mRNA CTD PMID:24449571 arsane multiple interactions ISO RGD:1347423 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of HLA-G mRNA CTD PMID:32525701 arsenic atom multiple interactions ISO RGD:1347423 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of HLA-G mRNA CTD PMID:32525701 arsenous acid decreases expression ISO RGD:1347423 6480464 Arsenic Trioxide results in decreased expression of HLA-G mRNA CTD PMID:15725085 more ... benzo[a]pyrene affects methylation ISO RGD:1347423 6480464 Benzo(a)pyrene affects the methylation of HLA-G 5' UTR CTD PMID:27901495 benzo[a]pyrene multiple interactions ISO RGD:11205 6480464 AHR protein affects the reaction [Benzo(a)pyrene affects the expression of H2-M3 mRNA] CTD PMID:22228805 benzo[a]pyrene increases expression ISO RGD:11205 6480464 Benzo(a)pyrene results in increased expression of H2-M3 mRNA CTD PMID:22228805 benzo[a]pyrene increases methylation ISO RGD:1347423 6480464 Benzo(a)pyrene results in increased methylation of HLA-G promoter CTD PMID:27901495 benzo[a]pyrene diol epoxide I increases expression ISO RGD:1347423 6480464 7 more ... CTD PMID:19150397 bifenthrin multiple interactions ISO RGD:1347423 6480464 Fulvestrant inhibits the reaction [bifenthrin results in increased expression of HLA-G mRNA] CTD PMID:24938463 bifenthrin increases expression ISO RGD:1347423 6480464 bifenthrin results in increased expression of HLA-G mRNA CTD PMID:24938463 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of HLA-G mRNA CTD PMID:25181051 bisphenol A affects methylation ISO RGD:1347423 6480464 bisphenol A affects the methylation of HLA-G gene CTD PMID:31601247 bisphenol A multiple interactions ISO RGD:1347423 6480464 [bisphenol A co-treated with Fulvestrant] results in decreased methylation of HLA-G gene CTD PMID:31601247 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of RT1-M3-1 mRNA CTD PMID:34947998 bisphenol A decreases expression ISO RGD:1347423 6480464 bisphenol A results in decreased expression of HLA-G mRNA, bisphenol A results in decreased expression of HLA-G protein CTD PMID:33953208 bisphenol A decreases methylation ISO RGD:1347423 6480464 bisphenol A results in decreased methylation of HLA-G promoter CTD PMID:33953208 bisphenol F multiple interactions ISO RGD:1347423 6480464 [bisphenol F co-treated with Fulvestrant] results in decreased methylation of HLA-G gene CTD PMID:31601247 bumetanide affects expression ISO RGD:1347423 6480464 Bumetanide affects the expression of HLA-G mRNA CTD PMID:25811541 cadmium atom affects methylation ISO RGD:1347423 6480464 Cadmium affects the methylation of HLA-G promoter CTD PMID:36370079 cadmium dichloride decreases methylation EXP 6480464 Cadmium Chloride results in decreased methylation of RT1-M3-1 promoter CTD PMID:22457795 carbamazepine affects expression ISO RGD:1347423 6480464 Carbamazepine affects the expression of HLA-G mRNA CTD PMID:25811541 carbon nanotube affects expression ISO RGD:11205 6480464 Nanotubes, Carbon affects the expression of H2-M3 mRNA CTD PMID:25554681 cefadroxil affects expression ISO RGD:1347423 6480464 Cefadroxil affects the expression of HLA-G mRNA CTD PMID:25811541 cefazolin affects expression ISO RGD:1347423 6480464 Cefazolin affects the expression of HLA-G mRNA CTD PMID:25811541 choline multiple interactions ISO RGD:11205 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of H2-M3 mRNA CTD PMID:20938992 ciguatoxin CTX1B affects expression ISO RGD:11205 6480464 Ciguatoxins affects the expression of H2-M3 mRNA CTD PMID:18353800 ciprofloxacin affects expression ISO RGD:1347423 6480464 Ciprofloxacin affects the expression of HLA-G mRNA CTD PMID:25811541 cisplatin multiple interactions ISO RGD:1347423 6480464 [Piroxicam co-treated with Cisplatin] results in increased expression of HLA-G mRNA CTD PMID:21858171 cisplatin affects response to substance ISO RGD:1347423 6480464 HLA-G protein affects the susceptibility to Cisplatin CTD PMID:16217747 cobalt dichloride increases expression ISO RGD:1347423 6480464 cobaltous chloride results in increased expression of HLA-G mRNA CTD PMID:19376846 cyclosporin A increases expression ISO RGD:1347423 6480464 Cyclosporine results in increased expression of HLA-G mRNA CTD PMID:22147139 decabromodiphenyl ether increases expression EXP 6480464 decabromobiphenyl ether results in increased expression of RT1-M3-1 mRNA CTD PMID:23640034 dexamethasone increases expression ISO RGD:11205 6480464 Dexamethasone results in increased expression of H2-M3 mRNA CTD PMID:21041162 dextran sulfate multiple interactions ISO RGD:11205 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of H2-M3 mRNA CTD PMID:29950665 diarsenic trioxide decreases expression ISO RGD:1347423 6480464 Arsenic Trioxide results in decreased expression of HLA-G mRNA CTD PMID:15725085 more ... diethyl malate affects expression ISO RGD:11205 6480464 diethyl malate affects the expression of H2-M3 mRNA CTD PMID:24814887 disodium selenite increases expression ISO RGD:1347423 6480464 Sodium Selenite results in increased expression of HLA-G mRNA CTD PMID:18175754 dorsomorphin multiple interactions ISO RGD:1347423 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor affects expression ISO RGD:1347423 6480464 Angiotensin-Converting Enzyme Inhibitors affects the expression of HLA-G mRNA CTD PMID:25811541 elemental selenium increases expression ISO RGD:1347423 6480464 Selenium results in increased expression of HLA-G mRNA CTD PMID:19244175 entinostat increases expression ISO RGD:1347423 6480464 entinostat results in increased expression of HLA-G mRNA CTD PMID:27188386 epoxiconazole decreases expression ISO RGD:11205 6480464 epoxiconazole results in decreased expression of H2-M3 mRNA CTD PMID:35436446 erythromycin A affects expression ISO RGD:1347423 6480464 Erythromycin affects the expression of HLA-G mRNA CTD PMID:25811541 flavonoids decreases expression EXP 6480464 Flavonoids results in decreased expression of H2-M3 mRNA CTD PMID:18035473 folic acid multiple interactions ISO RGD:11205 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of H2-M3 mRNA CTD PMID:20938992 fulvestrant multiple interactions ISO RGD:1347423 6480464 [bisphenol A co-treated with Fulvestrant] results in decreased methylation of HLA-G gene more ... CTD PMID:24938463 , PMID:31601247 furan increases expression EXP 6480464 furan results in increased expression of RT1-M3-1 mRNA CTD PMID:25539665 glimepiride affects expression ISO RGD:1347423 6480464 glimepiride affects the expression of HLA-G mRNA CTD PMID:25811541 ifosfamide affects expression ISO RGD:1347423 6480464 Ifosfamide affects the expression of HLA-G mRNA CTD PMID:25811541 indole-3-methanol affects expression EXP 6480464 indole-3-carbinol affects the expression of RT1-M3-1 mRNA CTD PMID:21396975 isotretinoin increases expression ISO RGD:1347423 6480464 Isotretinoin results in increased expression of HLA-G mRNA CTD PMID:20436886 ketorolac affects expression ISO RGD:1347423 6480464 Ketorolac affects the expression of HLA-G mRNA CTD PMID:25811541 L-methionine multiple interactions ISO RGD:11205 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of H2-M3 mRNA CTD PMID:20938992 lisinopril dihydrate affects expression ISO RGD:1347423 6480464 Lisinopril affects the expression of HLA-G mRNA CTD PMID:25811541 meropenem affects expression ISO RGD:1347423 6480464 Meropenem affects the expression of HLA-G mRNA CTD PMID:25811541 methotrexate affects response to substance ISO RGD:1347423 6480464 HLA-G gene polymorphism affects the susceptibility to Methotrexate CTD PMID:16906016 methotrexate increases expression ISO RGD:1347423 6480464 Methotrexate results in increased expression of HLA-G protein modified form CTD PMID:16906016 methotrexate decreases expression ISO RGD:1347423 6480464 Methotrexate results in decreased expression of HLA-G mRNA CTD PMID:17400583 mifepristone multiple interactions ISO RGD:1347423 6480464 Mifepristone inhibits the reaction [Progesterone results in increased expression of HLA-G mRNA], Mifepristone inhibits the reaction [Progesterone results in increased expression of HLA-G protein] CTD PMID:16210391 , PMID:22490650 Muraglitazar decreases expression EXP 6480464 muraglitazar results in decreased expression of RT1-M3-1 mRNA CTD PMID:21515302 N-nitrosodimethylamine increases expression EXP 6480464 Dimethylnitrosamine results in increased expression of RT1-M3-1 mRNA CTD PMID:25380136 Octicizer decreases expression ISO RGD:1347423 6480464 2-ethylhexyldiphenylphosphate results in decreased expression of HLA-G protein CTD PMID:35503735 omeprazole affects expression ISO RGD:1347423 6480464 Omeprazole affects the expression of HLA-G mRNA CTD PMID:25811541 ozone multiple interactions ISO RGD:11205 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of H2-M3 mRNA CTD PMID:34911549 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of RT1-M3-1 mRNA CTD PMID:33387578 paracetamol affects expression ISO RGD:11205 6480464 Acetaminophen affects the expression of H2-M3 mRNA CTD PMID:17562736 phenylmercury acetate increases expression ISO RGD:1347423 6480464 Phenylmercuric Acetate results in increased expression of HLA-G mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:1347423 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HLA-G mRNA CTD PMID:27188386 piroxicam multiple interactions ISO RGD:1347423 6480464 [Piroxicam co-treated with Cisplatin] results in increased expression of HLA-G mRNA CTD PMID:21858171 progesterone multiple interactions ISO RGD:1347423 6480464 Mifepristone inhibits the reaction [Progesterone results in increased expression of HLA-G mRNA], Mifepristone inhibits the reaction [Progesterone results in increased expression of HLA-G protein] CTD PMID:16210391 , PMID:22490650 progesterone increases expression ISO RGD:1347423 6480464 Progesterone results in increased expression of HLA-G mRNA, Progesterone results in increased expression of HLA-G protein CTD PMID:16210391 more ... pyrimethamine affects expression ISO RGD:1347423 6480464 Pyrimethamine affects the expression of HLA-G mRNA CTD PMID:25811541 rifampicin affects expression ISO RGD:1347423 6480464 Rifampin affects the expression of HLA-G mRNA CTD PMID:25811541 SB 431542 multiple interactions ISO RGD:1347423 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 selenium atom increases expression ISO RGD:1347423 6480464 Selenium results in increased expression of HLA-G mRNA CTD PMID:19244175 silver atom increases expression ISO RGD:11205 6480464 Silver results in increased expression of H2-M3 mRNA CTD PMID:27131904 silver(0) increases expression ISO RGD:11205 6480464 Silver results in increased expression of H2-M3 mRNA CTD PMID:27131904 sodium arsenate multiple interactions ISO RGD:1347423 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of HLA-G mRNA CTD PMID:32525701 sodium hydroxide affects response to substance ISO RGD:1347423 6480464 HLA-G SNP affects the susceptibility to Sodium Hydroxide CTD PMID:27258892 sulfamethoxazole affects expression ISO RGD:1347423 6480464 Sulfamethoxazole affects the expression of HLA-G mRNA CTD PMID:25811541 sulforaphane decreases expression ISO RGD:1347423 6480464 sulforaphane results in decreased expression of HLA-G mRNA CTD PMID:31838189 tamibarotene increases expression ISO RGD:1347423 6480464 tamibarotene results in increased expression of HLA-G mRNA CTD PMID:15498508 Tesaglitazar decreases expression EXP 6480464 tesaglitazar results in decreased expression of RT1-M3-1 mRNA CTD PMID:21515302 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of RT1-M3-1 mRNA CTD PMID:31150632 titanium dioxide multiple interactions ISO RGD:11205 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of H2-M3 mRNA CTD PMID:29950665 Tributyltin oxide increases expression ISO RGD:11205 6480464 bis(tri-n-butyltin)oxide results in increased expression of H2-M3 mRNA CTD PMID:18958704 valproic acid multiple interactions ISO RGD:1347423 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HLA-G mRNA CTD PMID:27188386 valproic acid affects expression ISO RGD:11205 6480464 Valproic Acid affects the expression of H2-M3 mRNA CTD PMID:17292431 , PMID:17963808 valproic acid increases expression ISO RGD:1347423 6480464 Valproic Acid results in increased expression of HLA-G mRNA CTD PMID:19101580 more ... valproic acid affects expression ISO RGD:1347423 6480464 Valproic Acid affects the expression of HLA-G mRNA CTD PMID:25979313 vitamin E increases expression ISO RGD:1347423 6480464 Vitamin E results in increased expression of HLA-G mRNA CTD PMID:19244175 vorinostat increases expression ISO RGD:1347423 6480464 Vorinostat results in increased expression of HLA-G mRNA CTD PMID:27188386 zinc atom increases expression ISO RGD:1347423 6480464 Zinc deficiency results in increased expression of HLA-G mRNA CTD PMID:18356318 zinc(0) increases expression ISO RGD:1347423 6480464 Zinc deficiency results in increased expression of HLA-G mRNA CTD PMID:18356318
